Consultant

• Feb 2023 - Present

Treasurer/Finance Manager

• May 2021 - Jan 2023

-Manage ASUCR/SOBA budgets and external account-Directed organizational grant & budget requisitions applications -Track, approve, and manage organizational transactions and reimbursements-Negotiate monetary allocations and appropriations

Sponsorships

• Mar 2020 - Jun 2021

-Corporate and departmental Sponsorship fund acquisitions.-Tracked revenue on Excel (including linear programming, excel solver, pivot tables.)-Event Planning

Equity Analyst-Healthcare Sector

• Oct 2019 - Sep 2022

-Responsible for reviewing/screening individual company balance sheets, cash flow statements, and annual 10-k reports, and developing discounted cash flow (DCF) reports. -Analyzed yearly/quarterly net income/revenue growth rates, 5m beta, quarterly EPS, market share, and various other company fundamentals. Metrics were recorded on Excel.-Assist in creating pitch decks relaying DCF and comparables model interpretations for large-cap healthcare stocks.

Intern

• Dec 2018 - Oct 2019

-Calculated price to earnings ratios, current ratios, debt to asset ratios etc. for various large cap stocks within the healthcare sector. -Compiled spreadsheets displaying quarterly net income, revenue, and P/E ratios of prospective stock picks using Microsoft Excel program.

Research Assistant

• Sep 2019 - Sep 2022

-Endocannabinoid research at lab of Dr. Nicholas DiPatrizio, Assistant Professor of Biomedical Sciences at UC Riverside School of Medicine. -Developed experimental models to study the effect of hyperlipidemic conditions on concentrations of 2-arachidonoylglycerol and anandamide in mice model. -Investigated the impact of CB1/CB2 receptor knockout, antagonism, and activation on metabolic function and oxidative stress for in vivo experimental models. -Endocannabinoid research at lab of Dr. Nicholas DiPatrizio, Assistant Professor of Biomedical Sciences at UC Riverside School of Medicine. -Developed experimental models to study the effect of hyperlipidemic conditions on concentrations of 2-arachidonoylglycerol and anandamide in mice model. -Investigated the impact of CB1/CB2 receptor knockout, antagonism, and activation on metabolic function and oxidative stress for in vivo experimental models.

Biomedical Researcher

• Nov 2018 - Jan 2022

-Worked in the laboratory of Principal Investigator Dr. Moti L. Kashyap, M.D. -Tested the effects of niacin on mitigating reactive oxygen species in human nonalcoholic steatohepatitis stellate cell model. -Analyzed relationship between TGF-beta protein and collagen types I and III/various fibrosis and inflammation biomarkers (including Tumor Necrosis Factor- alpha) in human stellate cells. Abstract published in Hepatology Paper published in American Journal of Translational Research https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274597/pdf/ajtr0014-4006.pdf Show less

Clinical Research Assistant

• Jul 2021 - Oct 2021

-Uitlized CPRS database, Genisis platform, and MS Excel to recruit patients for clinical studies including betaine research for reversing NAFLD in diagnosed patients. - Tracked and managed 12 patient dosing diary data points, BMP, and vitals using Excel and RedCap data managment software -Million Veterans Program -Uitlized CPRS database, Genisis platform, and MS Excel to recruit patients for clinical studies including betaine research for reversing NAFLD in diagnosed patients. - Tracked and managed 12 patient dosing diary data points, BMP, and vitals using Excel and RedCap data managment software -Million Veterans Program

Private Equity Intern

• May 2021 - Sep 2021

-Buy-side finance, targeting mid-sized founder-led companies. -Buy-side finance, targeting mid-sized founder-led companies.

Undergraduate Research Intern

• Jul 2019 - Oct 2019

-Tested multiple CKD models for proteinuria and creatinine levels as biomarkers for chronic renal injury in several mice nephropathy models. -Developed experiments to test PCSK9 inhibitors and their effect on low density lipoprotein levels in animal models. -Tested angiotensin receptor blockers (ARBs) for their effects on Reactive Oxygen Species (oxidative stress biomarker) and collagen I/III levels in renal cells of various animal nephropathy models. -Tested multiple CKD models for proteinuria and creatinine levels as biomarkers for chronic renal injury in several mice nephropathy models. -Developed experiments to test PCSK9 inhibitors and their effect on low density lipoprotein levels in animal models. -Tested angiotensin receptor blockers (ARBs) for their effects on Reactive Oxygen Species (oxidative stress biomarker) and collagen I/III levels in renal cells of various animal nephropathy models.